Exosomes are nano-sized vesicles released by different cell types, that can be found in the blood and other body fluids. They are intensely researched as carriers of biomarkers for a wide range of diseases, including cancer and cardiovascular diseases. Investigating these tiny vesicles in blood is currently a tedious and inefficient process, and the lack of a feasible and standardized solution for separation of exosomes from blood has hindered exosome biomarker discovery, validation and translation of research in any blood-based diagnostics to-date. The goal of AcouSome project is to develop a miniaturized microfluidic module for exosome isolation directly from blood using ultrasound generated by thin films, to be used across wide research and next generation diagnostics applications.
AcouSome is a project funded by the European Union.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Lund, Se
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.acousome.com/
- HQ
- Lund
Acousome Questions
Acousome's website is https://www.acousome.com/
Acousome's LinkedIn profile is https://se.linkedin.com/company/acousome
Acousome has
1 employees.
View email and phone details for 1
employees at Acousome.
Acousome's industry is
Biotechnology Research
Acousome's top competitors are
Cellwave Technologies,
Linak Scandinavia Ab,
Acousort Ab,
Cellqualia™️ - Sinfonia Technology Co..ltd.,
Direkt Studios,
Lundatec Ab,
I-Dialco,
Indicell,
Oe Bio,
Croyez Bioscience.
Acousome's categories are Biotechnology Research
Acousome's founding year is 2023
